Back to Search
Start Over
[18]F-fluoroethyl-l-tyrosine positron emission tomography for radiotherapy target delineation: Results from a Radiation Oncology credentialing program.
- Source :
-
Physics and imaging in radiation oncology [Phys Imaging Radiat Oncol] 2024 Mar 13; Vol. 30, pp. 100568. Date of Electronic Publication: 2024 Mar 13 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- Background and Purpose: The [18]F-fluoroethyl-l-tyrosine (FET) PET in Glioblastoma (FIG) study is an Australian prospective, multi-centre trial evaluating FET PET for newly diagnosed glioblastoma management. The Radiation Oncology credentialing program aimed to assess the feasibility in Radiation Oncologist (RO) derivation of standard-of-care target volumes (TV <subscript>MR</subscript> ) and hybrid target volumes (TV <subscript>MR+FET</subscript> ) incorporating pre-defined FET PET biological tumour volumes (BTVs).<br />Materials and Methods: Central review and analysis of TV <subscript>MR</subscript> and TV <subscript>MR+FET</subscript> was undertaken across three benchmarking cases. BTVs were pre-defined by a sole nuclear medicine expert. Intraclass correlation coefficient (ICC) confidence intervals (CIs) evaluated volume agreement. RO contour spatial and boundary agreement were evaluated (Dice similarity coefficient [DSC], Jaccard index [JAC], overlap volume [OV], Hausdorff distance [HD] and mean absolute surface distance [MASD]). Dose plan generation (one case per site) was assessed.<br />Results: Data from 19 ROs across 10 trial sites (54 initial submissions, 8 resubmissions requested, 4 conditional passes) was assessed with an initial pass rate of 77.8 %; all resubmissions passed. TV <subscript>MR+FET</subscript> were significantly larger than TV <subscript>MR</subscript> (p < 0.001) for all cases. RO gross tumour volume (GTV) agreement was moderate-to-excellent for GTV <subscript>MR</subscript> (ICC = 0.910; 95 % CI, 0.708-0.997) and good-to-excellent for GTV <subscript>MR+FET</subscript> (ICC = 0.965; 95 % CI, 0.871-0.999). GTV <subscript>MR+FET</subscript> showed greater spatial overlap and boundary agreement compared to GTV <subscript>MR</subscript> . For the clinical target volume (CTV), CTV <subscript>MR+FET</subscript> showed lower average boundary agreement versus CTV <subscript>MR</subscript> (MASD: 1.73 mm vs. 1.61 mm, p = 0.042). All sites passed the planning exercise.<br />Conclusions: The credentialing program demonstrated feasibility in successful credentialing of 19 ROs across 10 sites, increasing national expertise in TV <subscript>MR+FET</subscript> delineation.<br />Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (© 2024 The Author(s).)
Details
- Language :
- English
- ISSN :
- 2405-6316
- Volume :
- 30
- Database :
- MEDLINE
- Journal :
- Physics and imaging in radiation oncology
- Publication Type :
- Academic Journal
- Accession number :
- 38585372
- Full Text :
- https://doi.org/10.1016/j.phro.2024.100568